UK Artificial Intelligence In Drug Discovery Market Size & Outlook
UK artificial intelligence in drug discovery market, 2018-2030 (US$M)
Related Markets
UK artificial intelligence in drug discovery market highlights
- The UK artificial intelligence in drug discovery market generated a revenue of USD 87.2 million in 2023 and is expected to reach USD 544.5 million by 2030.
- The UK market is expected to grow at a CAGR of 29.9% from 2024 to 2030.
- In terms of segment, oncology was the largest revenue generating therapeutic space in 2023.
- Infectious Disease is the most lucrative therapeutic space segment registering the fastest growth during the forecast period.
Artificial intelligence in drug discovery market data book summary
| Market revenue in 2023 | USD 87.2 million |
| Market revenue in 2030 | USD 544.5 million |
| Growth rate | 29.9% (CAGR from 2024 to 2030) |
| Largest segment | Oncology |
| Fastest growing segment | Infectious Disease |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Oncology, Neurodegenerative Diseases, Cardiovascular Disease, Metabolic Diseases, Infectious Disease, Other |
Other key industry trends
- In terms of revenue, UK accounted for 5.9% of the global artificial intelligence in drug discovery market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, UK artificial intelligence in drug discovery market is projected to lead the regional market in terms of revenue in 2030.
- France is the fastest growing regional market in Europe and is projected to reach USD 309.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Artificial Intelligence in Drug Discovery Market Scope
Artificial Intelligence in Drug Discovery Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UK artificial intelligence in drug discovery market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to artificial intelligence in drug discovery market will help companies and investors design strategic landscapes.
Oncology was the largest segment with a revenue share of 22.48% in 2023. Horizon Databook has segmented the UK artificial intelligence in drug discovery market based on oncology, neurodegenerative diseases, cardiovascular disease, metabolic diseases, infectious disease, other covering the revenue growth of each sub-segment from 2018 to 2030.
A well-established healthcare sector, increasing number of patients suffering from chronic diseases, and manufacturers looking to reduce manufacturing costs of drug development are factors boosting the market in the UK. Increasing investment by major players in biopharma companies and growing public & private partnerships for R&D activities are other factors anticipated to boost the market over the coming years.
To keep up with countries such as the U.S. and China, in February 2019, the UK government announced to fund thousands of postgraduates to study masters in AI, as it is a significant technology that can have a major impact on several industries, including healthcare.
The government is expected to commit up to GBP 115 million to train students in AI technology. This is expected to create more jobs in the market. For instance, according to CNBC news, in 2018, Babylon Health announced an investment of USD 100 million to create more than 1,000 jobs in London.
Reasons to subscribe to UK artificial intelligence in drug discovery market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UK artificial intelligence in drug discovery market databook
-
Our clientele includes a mix of artificial intelligence in drug discovery market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UK artificial intelligence in drug discovery market , including forecasts for subscribers. This country databook contains high-level insights into UK artificial intelligence in drug discovery market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UK artificial intelligence in drug discovery market size, by therapeutic space, 2018-2030 (US$M)
UK Artificial Intelligence in Drug Discovery Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
